AV

Anju Varshney

Active Director Director DIN 08499749
DIN 08499749 First appointment Jul 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Anju Varshney

Data last updated:

Anju Varshney is a Director at Aldidrugs Pharmaceutical Private Limited (since 2019). The company operates in Pharma.

DIN 08499749
Primary Designation Director
Industry Pharma
First Appointment 04 Jul 2019
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jul 20192014Active

Directorship timeline

Open interactive timeline →
Aldidrugs Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Anju Varshney

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anju Varshney

Anju Varshney currently holds 1 directorship: Aldidrugs Pharmaceutical Private Limited (Director, since 04 Jul 2019).

Anju Varshney was first appointed on 04 Jul 2019 as Director at Aldidrugs Pharmaceutical Private Limited.

The current boards of Anju Varshney's companies include Ekta Gupta (Aldidrugs Pharmaceutical Private Limited), Prashant Varshney (Aldidrugs Pharmaceutical Private Limited), Ruchi Singhal (Aldidrugs Pharmaceutical Private Limited), Sumit Singhal (Aldidrugs Pharmaceutical Private Limited), Yogesh Kumar Varshney (Aldidrugs Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available